Big future premium attached, would be interested if the exercise price was lower, been stung with oppies in the past, even though not too far off yearly high
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025